Compared with non-Asian populations, Asian NSCLC patients exhibit a higher prevalence of EGFR mutations, distinct immune-related gene expression profiles, and specific gut microbiome compositions that can modulate the tumor immune microenvironment (54). Here, EGFR is linked to neoplasm.